Evidence map›Paper›PMID 42541253›Full record

ArticleJSES international2026

Mixed reality with real-time navigation grants low deviations from planned inclination and version of the glenoid for reverse total shoulder arthroplasty.

Maxime Antoni, Guillaume Marzolf, Benoit Mariotte, ReSurg, Franck Dordain

Abstract read
In one paragraph

Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maxime AntoniClinique de l'Orangerie, ELSAN, Strasbourg, France.
Guillaume MarzolfClinique de l'Orangerie, ELSAN, Strasbourg, France.
Benoit MariotteHopital Privé Saint Martin, Ramsay Santé, Caen, France.
ReSurg
Franck DordainHopital Privé Saint Martin, Ramsay Santé, Caen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Correct glenoid version and inclination can limit scapular notching, instability, and glenoid loosening in reverse total shoulder arthroplasty (rTSA). Traditionally, planned trajectories were displayed on a screen close to the operating table and reproduced freehand intraoperatively. Mixed reality planning has emerged, using superimposition of the scapular hologram on the patient's glenoid, with intended trajectories and real-time navigation to provide more accurate guidance. The purpose was to assess the implant version and inclination in rTSA using mixed reality with navigation. Methods: The authors retrospectively assessed a series of 45 shoulders that underwent rTSA using mixed reality with navigation using a head-mounted display. Computed tomography scans were acquired for each shoulder and imported into Shoulder+ to plan the rTSA and define the target inclination and version. The head-mounted display was used to display an interactive hologram over the operative site to navigate the guidewire. Pre-operative and 6-month post-operative scans were performed, and version and inclination of the implant were measured. Results: The final cohort comprised 35 shoulders, aged 75.5 ± 7.3 years. Additional operative time was 10.1 ± 2.5 minutes. The absolute deviation between post-operative and planned version was 2.8° ± 2.0 ( Conclusion: rTSA with mixed reality navigation enables accurate glenoid implant positioning, with minimal deviations from planning. However, surgeons should be aware of the additional time required.

Indexed as

AccuracyAugmented realityIntraoperativeMixed realityPlanningPre-operative planningShoulderShoulder arthroplasty

Identifiers

PMID42541253
PMCPMC13427434

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.